C1QL1 protein identified as key to myelin replacement
Can't see this email? View it online
   
  Multiple Sclerosis Multiple Sclerosis logo  
  The latest multiple sclerosis news from News Medical  
 Study uncovers ancestry-specific genetic links to multiple sclerosis riskStudy uncovers ancestry-specific genetic links to multiple sclerosis risk
 
A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations affected by the disease.
 
 
 C1QL1 protein identified as key to myelin replacementC1QL1 protein identified as key to myelin replacement
 
The neurons of the brain are protected by an insulating layer called myelin. In certain diseases like multiple sclerosis, this protective layer is damaged and lost, leading to death of neurons and disability.
 
   Study reveals biomarkers that predict disability worsening in multiple sclerosisStudy reveals biomarkers that predict disability worsening in multiple sclerosis
 
A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).
 
 Therapeutic inertia in the treatment of women with multiple sclerosis revealed
 
Therapeutic inertia in the treatment of women with multiple sclerosis revealedA study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.
 
 
 $1 million grant awarded to explore myelin repair mechanisms in multiple sclerosis
 
$1 million grant awarded to explore myelin repair mechanisms in multiple sclerosisThe National Multiple Sclerosis Society (USA) has awarded a grant of 1 million dollars to Dr. Isabel Pérez-Otaño, who leads the Plasticity and Remodeling of Neural Circuits laboratory at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University (UMH) of Elche.
 
 
 Early intervention in pediatric-onset MS can lead to improved long-term outcomes
 
Early intervention in pediatric-onset MS can lead to improved long-term outcomesNew research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.